SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-22-025265
Filing Date
2022-09-07
Accepted
2022-09-07 16:46:00
Documents
17
Period of Report
2022-08-31
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 54061
2 ex2-1.htm EX-2.1 270779
3 ex10-1.htm EX-10.1 84146
4 ex99-1.htm EX-99.1 15892
5 ex99-2.htm EX-99.2 121913
6 ex99-1_001.jpg GRAPHIC 3600
  Complete submission text file 0001493152-22-025265.txt   813524

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE idxg-20220831.xsd EX-101.SCH 3230
8 XBRL LABEL FILE idxg-20220831_lab.xml EX-101.LAB 34916
9 XBRL PRESENTATION FILE idxg-20220831_pre.xml EX-101.PRE 22791
11 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3584
Mailing Address MORRIS CORPORATE CENTER 1, BUILDING C, 300 INTERPACE PARKWAY PARSIPPANY NJ 07054
Business Address MORRIS CORPORATE CENTER 1, BUILDING C, 300 INTERPACE PARKWAY PARSIPPANY NJ 07054 412-224-6100
INTERPACE BIOSCIENCES, INC. (Filer) CIK: 0001054102 (see all company filings)

IRS No.: 222919486 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-24249 | Film No.: 221231655
SIC: 3841 Surgical & Medical Instruments & Apparatus